RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 3.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,995 | -16.3% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,105 | -2.3% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $19,549 | -27.9% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $27,102 | +59.4% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $17,000 | +6.2% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $16,000 | -63.6% | 14,810 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $44,000 | +12.8% | 14,810 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $39,000 | -27.8% | 14,810 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $54,000 | -15.6% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $64,000 | +25.5% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $51,000 | -1.9% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $52,000 | +44.4% | 14,810 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $36,000 | +56.5% | 14,810 | +17.4% | 0.00% | +100.0% |
| Q2 2020 | $23,000 | +15.0% | 12,610 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $20,000 | -25.9% | 12,610 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $27,000 | +12.5% | 12,610 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $24,000 | -27.3% | 12,610 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $33,000 | +3.1% | 12,610 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $32,000 | +10.3% | 12,610 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $29,000 | -27.5% | 12,610 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $40,000 | +11.1% | 12,610 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $36,000 | -20.0% | 12,610 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $45,000 | +12.5% | 12,610 | +21.4% | 0.00% | 0.0% |
| Q4 2017 | $40,000 | +53.8% | 10,390 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $26,000 | -7.1% | 10,390 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $28,000 | +12.0% | 10,390 | +36.9% | 0.00% | 0.0% |
| Q1 2017 | $25,000 | – | 7,590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |